These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28726562)

  • 1. Gene therapy for age-related macular degeneration.
    Moore NA; Bracha P; Hussain RM; Morral N; Ciulla TA
    Expert Opin Biol Ther; 2017 Oct; 17(10):1235-1244. PubMed ID: 28726562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration.
    Hussain RM; Ciulla TA
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):235-246. PubMed ID: 28756707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond.
    Rowe LW; Ciulla TA
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
    Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
    J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Hypoxia-Regulated Retinal Pigment Epithelium-Specific Gene Therapy Vector Reduces Choroidal Neovascularization in a Mouse Model.
    Yuan Y; Kong W; Liu XM; Shi GH
    Curr Gene Ther; 2022; 22(5):417-426. PubMed ID: 35382718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
    Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q
    J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.
    Gelfman CM; Grishanin R; Bender KO; Nguyen A; Greengard J; Sharma P; Nieves J; Kiss S; Gasmi M
    J Ocul Pharmacol Ther; 2021 Apr; 37(3):181-190. PubMed ID: 33835848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization.
    Zhang X; Das SK; Passi SF; Uehara H; Bohner A; Chen M; Tiem M; Archer B; Ambati BK
    Mol Ther; 2015 Feb; 23(2):226-34. PubMed ID: 25306972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.
    Maclachlan TK; Lukason M; Collins M; Munger R; Isenberger E; Rogers C; Malatos S; Dufresne E; Morris J; Calcedo R; Veres G; Scaria A; Andrews L; Wadsworth S
    Mol Ther; 2011 Feb; 19(2):326-34. PubMed ID: 21119620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
    Sridhar J; Hsu J; Shahlaee A; Garg SJ; Spirn MJ; Fineman MS; Vander J
    JAMA Ophthalmol; 2016 Apr; 134(4):437-43. PubMed ID: 26914218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration.
    Liu Y; Fortmann SD; Shen J; Wielechowski E; Tretiakova A; Yoo S; Kozarsky K; Wang J; Wilson JM; Campochiaro PA
    Mol Ther; 2018 Feb; 26(2):542-549. PubMed ID: 29292162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.
    Yazdi MH; Faramarzi MA; Nikfar S; Falavarjani KG; Abdollahi M
    Expert Opin Biol Ther; 2015; 15(9):1349-58. PubMed ID: 26076760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration.
    Constable IJ; Pierce CM; Lai CM; Magno AL; Degli-Esposti MA; French MA; McAllister IL; Butler S; Barone SB; Schwartz SD; Blumenkranz MS; Rakoczy EP
    EBioMedicine; 2016 Dec; 14():168-175. PubMed ID: 27865764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
    Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
    Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues.
    Ziemssen F; Sobolewska B; Deissler H; Deissler H
    Expert Opin Drug Saf; 2016 Jan; 15(1):75-87. PubMed ID: 26568279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the pharmacotherapy of neovascular age-related macular degeneration.
    Freund KB; Mrejen S; Gallego-Pinazo R
    Expert Opin Pharmacother; 2013 Jun; 14(8):1017-28. PubMed ID: 23560774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.
    Díaz-Lezama N; Wu Z; Adán-Castro E; Arnold E; Vázquez-Membrillo M; Arredondo-Zamarripa D; Ledesma-Colunga MG; Moreno-Carranza B; Martinez de la Escalera G; Colosi P; Clapp C
    Lab Invest; 2016 Mar; 96(3):283-95. PubMed ID: 26568297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances in the treatment of neovascular age-related macular degeneration.
    Villegas VM; Aranguren LA; Kovach JL; Schwartz SG; Flynn HW
    Expert Opin Drug Deliv; 2017 Feb; 14(2):273-282. PubMed ID: 27434329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration.
    Grishanin R; Vuillemenot B; Sharma P; Keravala A; Greengard J; Gelfman C; Blumenkrantz M; Lawrence M; Hu W; Kiss S; Gasmi M
    Mol Ther; 2019 Jan; 27(1):118-129. PubMed ID: 30528929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.